Delivery Order SPE2DR25D2006-SPE2DR26F56AK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,099.73 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by August 26, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $2,309.32 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed price, competitively awarded delivery order was issued on November 10, 2025, with an ultimate completion date of November 12, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $7,069.90 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by June 10, 2025. The contract represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework with the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,132.72 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation medication used to treat chronic obstructive pulmonary disease. The contract, awarded on November 6, 2025, with an ultimate completion date of November 7, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating open and competitive procurement. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,752.46 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, issued on October 30, 2025, represents a non-set-aside, competitively awarded contract with an ultimate completion date of October 31, 2025. The product will be delivered to AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $1,855.39 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication supplied in a 60-dose inhaler. The contract, awarded on October 31, 2025, with completion targeted for November 3, 2025, was competitively awarded with no set-aside designation. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $15,954.18 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication supplied in 60-dose inhalers. This firm fixed-price delivery order, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order, valued at $8,689.85, is scheduled for completion by November 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a...
- The Defense Logistics Agency awarded a delivery order valued at $2,175.14 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a prescription respiratory medication used to treat chronic obstructive pulmonary disease. The contract was competitively awarded with firm fixed pricing and is classified as a non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 26,...
- The Defense Logistics Agency awarded a $13,601.21 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, awarded on August 28, 2025, represents a non-competed transaction executed under an existing contract vehicle and is scheduled for completion by August 29, 2025. The pharmaceutical products will be delivered to the company's distribution...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F56AKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,057.60 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease. The award, issued on November 12, 2025, represents a firm fixed price delivery order with an ultimate completion date of November 13, 2025. This contract was competitively awarded with no set-aside designation, leveraging AmerisourceBergen's established relationship with the federal government as a critical pharmaceutical supplier. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen maintains an extensive federal contract portfolio delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's federal procurement history demonstrates consistent capability to fulfill both small-value and substantial orders through open competition, supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 11/12/25 |